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Background
Optimal patients characterization in Heart Failure with Preserved Ejection Fraction (HFpEF) is essential to tailor successful treatment strategies.
Cardiac magnetic resonance derived T1-Mapping allows for non-invasive quantification of diffuse myocardial fibrosis as extracellular volume fraction (ECV).
We aimed to elucidate the diagnostic performance of T1-Mapping in HFpEF by examining the relationship between ECV and invasively measured parameters of diastolic function and investigated the potential of ECV to differentiate between different pathomechanisms in HFpEF.
Methods
We performed T1-Mapping in 21 patients with HFpEF and 11 patients without heart failure symptoms. Pressure-volume-loops were obtained with a conductance catheter during basal conditions and handgrip exercise. Transient preload reduction was used to extrapolate the diastolic stiffness constant.
Results
Patients with HFpEF showed a higher ECV (p = 0.001), an elevated load-independent passive LV-stiffnessconstant β (p < 0.001) and a longer time constant of active LV-relaxation τ (p = 0.04). ECV correlated highly with β (r = 0.75, p <0.001). After multivariate analysis, ECV remained the only independent predictor of β.
Within the HFpEF cohort, patients with ECV > median showed a higher LV-stiffness-constant (p = 0.05) whereas ECV < median identified patients with a prolonged active LV-relaxation (p = 0.01) and a marked hypertensive reaction to exercise due to a pathologic arterial elastance (p = 0.05).
Conclusions
Diffuse myocardial fibrosis, assessed by CMR derived T1-Mapping, independently predicts invasively measured LV stiffness in HFpEF. In addition, ECV helps to noninvasively distinguish the role of impaired active relaxation and passive stiffness. It also refines characterization of patients, which represents a prerequisite for any successful therapy in the future. 
